Aspect Biosystems picks up Series A

Vancouver, British Columbia-based Aspect Biosystems, a biotechnology company, has raised US$20 million in Series A financing.

9 January 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles